Maybe we should be looking into the same coarse of action...........

Block & Leviton LLP Investigates MAP Pharmaceuticals, Inc., for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Allergan, Inc.

 

Block & Leviton's investigation seeks to determine, among other things, whether MAP's Directors breached their fiduciary duties by failing to maximize shareholder value in the proposed acquisition by Allergan and the overall fairness of the process by which the MAP Directors considered and approved the transaction.